Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Critical Illness Insurance Market to reach USD XX billion by 2026.

Global Critical Illness Insurance Market Size study, by Type (Disease Insurance, Medical Insurance, Income Protection Insurance), by Application (Cancer, Heart Attack, Stroke) and Regional Forecasts 2019-2026

Product Code: BAFB_80550127
Publish Date: 15-05-2019
Page: 200

Global Critical Illness Insurance Market valued approximately USD XX billion in 2018 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. The Critical Illness Insurance Market is continuously growing across the world over the coming years. The major driving factor of global Critical Illness Insurance market are increasing benefit get from critical illness insurance and rising geriatric population across the globe. However, lack of awareness among the individuals is one of the major factor that hamper the global critical illness insurance market. Critical Illness Insurance is type insurance in which the insurer is contracted to typically make a lumpsum cash payment if the policyholder is diagnosed with one of the specific illness on a predetermined list as part of an insurance policy. Critical illness insurance is also known as critical insurance cover. Critical illness insurance offers various benefits such as high life cover at affordable rates, accidental death benefit, guaranteed benefit payout up to 1 crore in case of 34 life critical illness, protection against disability, tax benefit, 100% benefit payout and many more.
The regional analysis of Global Critical Illness Insurance Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific is the leading/significant region across the world in terms of market share in 2017 due to higher population growth in economy. The region comprises some of the fastest developing economies in the world including China, India, Japan and Korea. This has led to an increase in in insurance investment over the coming years. Europe and North America is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026.
The major market player included in this report are:
UnitedHealthcare
Wellpoint Inc.
DKV
BUPA
Kaiser Permanente
Aetna Inc.
PICC
PINGAN
Kunlun
Aflac
Metlife

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Disease Insurance
Medical Insurance
Income Protection Insurance

By Application:

Cancer
Heart Attack
Stroke

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Critical Illness Insurance Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Key Trends
1.3.Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.Critical Illness Insurance Market, by Type, 2016-2026 (USD Billion)
1.3.2.Critical Illness Insurance Market, by Application, 2016-2026 (USD Billion)
1.3.3.Critical Illness Insurance Market, by Region, 2016-2026 (USD Billion)
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Critical Illness Insurance Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Critical Illness Insurance Market Dynamics
3.1.See Saw Analysis
3.1.1.Market Drivers
3.1.2.Market Challenges
3.1.3.Market Opportunities
Chapter 4.Critical Illness Insurance Market Industry Analysis
4.1.Porter’s 5 Force Model
4.1.1.Bargaining Power of Buyers
4.1.2.Bargaining Power of Suppliers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter’s 5 Force Model
4.2.PEST Analysis
4.2.1.Political Scenario
4.2.2.Economic Scenario
4.2.3.Social Scenario
4.2.4.Technological Scenario
4.3.Value Chain Analysis
4.3.1.Supplier
4.3.2.Manufacturers/Service Provider
4.3.3.Distributors
4.3.4.End-Users
4.4.Key Buying Criteria
4.5.Regulatory Framework
4.6.Cost Structure Analysis
4.6.1.Raw Material Cost Analysis
4.6.2.Manufacturing Cost Analysis
4.6.3.Labour Cost Analysis
4.7.Investment Vs Adoption Scenario
4.8.Analyst Recommendation & Conclusion
Chapter 5.Critical Illness Insurance Market, by Type
5.1.Market Snapshot
5.2.Market Performance – Potential Model
5.3.Key Market Players
5.4.Critical Illness Insurance Market, Sub Segment Analysis
5.4.1.Disease Insurance
5.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.Medical Insurance
5.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.Income Protection Insurance
5.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.Critical Illness Insurance Market, by Application
6.1.Market Snapshot
6.2.Market Performance – Potential Model
6.3.Key Market Players
6.4.Critical Illness Insurance Market, Sub Segment Analysis
6.4.1.Cancer
6.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.Heart Attack
6.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.Stroke
6.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7.Critical Illness Insurance Market, by Regional Analysis
7.1.Critical Illness Insurance Market, Regional Market Snapshot (2016-2026)
7.2.North America Critical Illness Insurance Market Snapshot
7.2.1.U.S.
7.2.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.Canada
7.2.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.Europe Critical Illness Insurance Market Snapshot
7.3.1.U.K.
7.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.Germany
7.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.France
7.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.Rest of Europe
7.3.4.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.Asia Critical Illness Insurance Market Snapshot
7.4.1.China
7.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.India
7.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.Japan
7.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.Rest of Asia Pacific
7.4.4.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.Latin America Critical Illness Insurance Market Snapshot
7.5.1.Brazil
7.5.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.Mexico
7.5.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.Rest of The World
7.6.1.South America
7.6.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.Middle East and Africa
7.6.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.2.Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.3.Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8.Competitive Intelligence
8.1.Company Market Share (Subject to Data Availability)
8.2.Top Market Strategies
8.3.Company Profiles
8.3.1.UnitedHealthcare
8.3.1.1.Overview
8.3.1.2.Financial (Subject to Data Availability)
8.3.1.3.Product Summary
8.3.1.4.Recent Developments
8.3.2.Wellpoint Inc.
8.3.3.DKV
8.3.4.BUPA
8.3.5.Kaiser Permanente
8.3.6.Aetna Inc.
8.3.7.PICC
8.3.8.PINGAN
8.3.9.Kunlun
8.3.10.Aflac
8.3.11.Metlife
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.1.6.Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now